Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Hara S, Urabe F, Tashiro K, Goto Y, Iwamoto Y, Ohtsuka T, Fukuokaya W, Imai Y, Iwatani K, Atsuta M, Mori K, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Murakami M, Tsuzuki S, Yanada BA, Hata K, Furuta A, Yamada H, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group.
Hara S, et al. Among authors: hata k.
Jpn J Clin Oncol. 2024 Oct 19:hyae146. doi: 10.1093/jjco/hyae146. Online ahead of print.
Jpn J Clin Oncol. 2024.
PMID: 39426804